Concentra Group Holdings Parent (CON) Stock Price, News & Analysis

Company Overview

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

Key Stats

• Today's Range: $23.23 to $23.78
• 50-Day Range: $19.49 to $23.64
• 52-Week Range: $18.89 to $24.81
• Volume: 835,059 shs
• Average Volume: 936,700 shs
• Market Capitalization: $2.99 billion
• P/E Ratio: 19.23
• Dividend Yield: 1.07%
• Price Target: $27.50
• Consensus Rating: Buy

Concentra Group Holdings Parent Stock Analysis - MarketRank™

Concentra Group Holdings Parent scored higher than 45% of companies evaluated by MarketBeat, and ranked 609th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.5 / 5
• Analyst Rating: Buy

Consensus Rating

Concentra Group Holdings Parent has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Concentra Group Holdings Parent has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: -11.56%

Earnings Growth

Earnings for Concentra Group Holdings Parent are expected to decrease by -11.56% in the coming year, from $1.47 to $1.30 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Concentra Group Holdings Parent is 19.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.64.

Price to Earnings Ratio vs. Sector

The P/E ratio of Concentra Group Holdings Parent is 19.63, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.25.

Price to Earnings Growth Ratio

Concentra Group Holdings Parent has a PEG Ratio of 2.14. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Concentra Group Holdings Parent has a P/B Ratio of 10.62. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for CON.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Concentra Group Holdings Parent pays a meaningful dividend of 1.09%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Concentra Group Holdings Parent does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Concentra Group Holdings Parent is 21.01%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Concentra Group Holdings Parent will have a dividend payout ratio of 19.23% next year. This indicates that Concentra Group Holdings Parent will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for CON.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.47

News Sentiment

Concentra Group Holdings Parent has a news sentiment score of 1.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Concentra Group Holdings Parent this week, compared to 5 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Concentra Group Holdings Parent insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 6.60% of the stock of Concentra Group Holdings Parent is held by insiders.

CON Stock Analysis - Frequently Asked Questions

How have CON shares performed this year?

Concentra Group Holdings Parent's stock was trading at $19.78 at the beginning of 2025. Since then, CON shares have increased by 18.1% and is now trading at $23.3610.

How were Concentra Group Holdings Parent's earnings last quarter?

Concentra Group Holdings Parent, Inc. (NYSE:CON) announced its earnings results on Thursday, August, 7th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Concentra Group Holdings Parent's revenue was up 15.2% compared to the same quarter last year.
Read the conference call transcript.

When did Concentra Group Holdings Parent IPO?

Concentra Group Holdings Parent (CON) raised $529 million in an initial public offering on Thursday, July 25th 2024. The company issued 22,500,000 shares at a price of $23.50 per share.

Who are Concentra Group Holdings Parent's major shareholders?

Top institutional shareholders of Concentra Group Holdings Parent include State Street Corp (3.33%), JPMorgan Chase & Co. (2.68%), Geode Capital Management LLC (2.04%) and Norges Bank (1.17%).

How do I buy shares of Concentra Group Holdings Parent?

Shares of CON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concentra Group Holdings Parent own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concentra Group Holdings Parent investors own include Skye Bioscience (SKYE), CervoMed (CRVO), Core Scientific (CORZ), ChargePoint (CHPT), Carnival Co. & (CCL), Carrier Global (CARR) and Bit Digital (BTBT).

Company Calendar

• Record date for 5/29 Dividend: 5/20/2025
• Ex-Dividend for 5/29 Dividend: 5/20/2025
• Dividend Payable: 5/29/2025
• Last Earnings: 8/07/2025
• Record date for 8/28 Dividend: 8/21/2025
• Ex-Dividend for 8/28 Dividend: 8/21/2025
• Today: 8/25/2025
• Dividend Payable: 8/28/2025
• Next Earnings (Estimated): 10/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CON
• Previous Symbol: NYSE:CON
• CIK: 2014596
• Web: N/A
• Phone: (717) 972-1100
• Fax: N/A
• Employees: 11,250
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Concentra Group Holdings Parent: $27.50
• High Price Target: $30.00
• Low Price Target: $25.00
• Potential Upside/Downside: +17.7%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.19
• Trailing P/E Ratio: 19.23
• Forward P/E Ratio: 15.89
• P/E Growth: 2.14
• Net Income: $166.54 million
• Net Margins: 7.44%
• Pretax Margin: 10.47%
• Return on Equity: 50.84%
• Return on Assets: 5.89%

Debt

• Debt-to-Equity Ratio: 4.75
• Current Ratio: 1.18
• Quick Ratio: 1.18

Sales & Book Value

• Annual Sales: $1.90 billion
• Price / Sales: 1.58
• Cash Flow: $1.83 per share
• Price / Cash Flow: 12.80
• Book Value: $2.20 per share
• Price / Book: 10.62

Miscellaneous

• Outstanding Shares: 128,170,000
• Free Float: 119,712,000
• Market Cap: $2.99 billion
• Optionable: N/A
• Beta: N/A